pith. sign in

arxiv: 2505.20218 · v2 · pith:2UV767KRnew · submitted 2025-05-26 · 💻 cs.LG

Fine-grained List-wise Alignment for Generative Medication Recommendation

Chenxiao Fan , Chongming Gao , Wentao Shi , Yaxin Gong , Zihao Zhao , Fuli Feng This is my paper

Pith reviewed 2026-05-22 02:31 UTC · model grok-4.3

classification 💻 cs.LG
keywords medication recommendationlist-wise alignmentlarge language modelsdrug-drug interactionssequential decision processreinforcement learningclinical decision support
0
0 comments X

The pith

FLAME turns medication recommendation into a step-by-step process of adding or removing one drug at a time inside large language models.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper introduces FLAME to fix the shortcoming that current systems predict each drug independently and therefore overlook how drugs work together or harm one another. It recasts the task as a sequential decision sequence in which the model decides at every step whether to include or exclude a single drug, guided by a reward signal that scores the incremental effect on the full list. Structured clinical knowledge and patient collaboration data are folded into the model’s internal representations to make those step-by-step choices more informed. The result is claimed to produce lists that are simultaneously more accurate and more adjustable for safety in complex multimorbidity cases.

Core claim

FLAME formulates medication recommendation as a sequential decision process where each step adds or removes a single drug. Step-wise Group Relative Policy Optimization with potential-based reward shaping supplies fine-grained learning signals that explicitly model drug-drug interactions and the contribution of every individual drug to the overall prescription. Patient representations are strengthened by injecting structured clinical knowledge and collaborative information into the language model’s embedding space, yielding measurable gains in accuracy, safety-accuracy control, and generalization on clinical benchmarks.

What carries the argument

Step-wise Group Relative Policy Optimization (GRPO) with potential-based reward shaping that evaluates the effect of each single-drug change on the full prescription list.

If this is right

  • Enables explicit control over the safety-accuracy balance by adjusting the reward weights at each generation step.
  • Produces higher accuracy than point-wise baselines on standard medication recommendation benchmarks.
  • Maintains strong performance when applied to varied clinical scenarios with different patient populations.
  • Generates prescriptions by building the list drug by drug rather than predicting the entire set at once.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same single-item sequential framing could be tested on other list-generation problems that involve pairwise constraints, such as sequencing lab tests or composing care plans.
  • Embedding external clinical knowledge directly into the representation may reduce reliance on the model’s parametric memory for rare drug combinations.
  • Controllable trade-offs open the possibility of dynamically shifting the reward balance according to a patient’s documented risk tolerance during live use.

Load-bearing premise

The potential-based reward shaping inside the step-wise optimization correctly measures each drug’s true contribution and interaction effects without distortion from the chosen patient representation.

What would settle it

Retraining the same model on the benchmark datasets after disabling the potential-based reward shaping and checking whether drug-interaction violation rates rise or accuracy falls would directly test whether the shaping mechanism is necessary.

Figures

Figures reproduced from arXiv: 2505.20218 by Chenxiao Fan, Chongming Gao, Fuli Feng, Wentao Shi, Yaxin Gong, Zihao Zhao.

Figure 1
Figure 1. Figure 1: Contrasting advantage computation in GRPO and step-wise GRPO. (a) Outcome-based [PITH_FULL_IMAGE:figures/full_fig_p002_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: (a) Output is segmented by medication names into decision steps. (b) Each step is viewed [PITH_FULL_IMAGE:figures/full_fig_p005_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Illustration of the two-stage recommendation framework. [PITH_FULL_IMAGE:figures/full_fig_p006_3.png] view at source ↗
Figure 4
Figure 4. Figure 4: Overview of patient representation construction. [PITH_FULL_IMAGE:figures/full_fig_p007_4.png] view at source ↗
Figure 5
Figure 5. Figure 5: Comparison with strong baselines. (a) Safety–accuracy trade-off on MIMIC-III. (b) [PITH_FULL_IMAGE:figures/full_fig_p008_5.png] view at source ↗
Figure 6
Figure 6. Figure 6: Training curves of GRPO and step-wise GRPO. 5.3 Ablation Study We conduct ablations to assess the impact of each component in FLAME, including the list-wise decision model, step-wise GRPO, and multi-source knowledge fusion. List-wise Decision Model. We first examine the roles of πcls and πlist [PITH_FULL_IMAGE:figures/full_fig_p009_6.png] view at source ↗
read the original abstract

Accurate and safe medication recommendations are critical for effective clinical decision-making, especially in multimorbidity cases. However, existing systems rely on point-wise prediction paradigms that overlook synergistic drug effects and potential adverse drug-drug interactions (DDIs). We propose FLAME, a fine-grained list-wise alignment framework for large language models (LLMs), enabling drug-by-drug generation of drug lists. FLAME formulates recommendation as a sequential decision process, where each step adds or removes a single drug. To provide fine-grained learning signals, we devise step-wise Group Relative Policy Optimization (GRPO) with potential-based reward shaping, which explicitly models DDIs and optimizes the contribution of each drug to the overall prescription. Furthermore, FLAME enhances patient modeling by integrating structured clinical knowledge and collaborative information into the representation space of LLMs. Experiments on benchmark datasets demonstrate that FLAME achieves state-of-the-art performance, delivering superior accuracy, controllable safety-accuracy trade-offs, and strong generalization across diverse clinical scenarios. Our code is available at https://github.com/cxfann/Flame.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The manuscript presents FLAME, a fine-grained list-wise alignment framework for LLMs in generative medication recommendation. It formulates the task as a sequential decision process in which drugs are added or removed one at a time, using step-wise Group Relative Policy Optimization (GRPO) with potential-based reward shaping to model drug-drug interactions and assign credit to individual drugs. Patient representations are enriched by integrating structured clinical knowledge and collaborative information. Experiments on benchmark datasets report state-of-the-art accuracy, controllable safety-accuracy trade-offs, and strong generalization.

Significance. If the empirical results hold under rigorous evaluation, the work offers a meaningful advance over point-wise medication recommendation systems by enabling list-wise generative modeling with explicit handling of synergies and adverse interactions. The combination of GRPO, potential-based shaping, and knowledge-augmented representations provides a principled route to fine-grained optimization in a high-stakes domain, with the released code supporting reproducibility.

major comments (2)
  1. [§3.3] §3.3, reward shaping definition: the potential function Φ is constructed from DDI priors; it is unclear whether the ablation in Table 4 isolates the contribution of this prior from the evaluation metrics themselves, which is load-bearing for the claim of unbiased fine-grained credit assignment.
  2. [§4.3] §4.3, Table 2: superiority over baselines is reported, yet no error bars, multiple random seeds, or statistical significance tests are provided; this weakens the SOTA claim given the stochastic nature of LLM fine-tuning and GRPO.
minor comments (2)
  1. The description of how the safety-accuracy trade-off is controlled (via a hyperparameter in the shaped reward) is mentioned in the abstract but lacks a dedicated paragraph or figure in the main text.
  2. [§3.1] Notation for the state representation s_t and the group in GRPO overlaps with standard RL symbols; a short notation table would reduce ambiguity.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their constructive review and for recommending minor revision. We appreciate the positive evaluation of the significance of FLAME in advancing fine-grained list-wise alignment for medication recommendation. We address each major comment below and will incorporate the requested clarifications and improvements in the revised manuscript.

read point-by-point responses

  1. Referee: [§3.3] §3.3, reward shaping definition: the potential function Φ is constructed from DDI priors; it is unclear whether the ablation in Table 4 isolates the contribution of this prior from the evaluation metrics themselves, which is load-bearing for the claim of unbiased fine-grained credit assignment.

    Authors: We thank the referee for this observation on the reward shaping and ablation clarity. The potential function Φ is constructed from DDI priors specifically to shape step-wise rewards and model interactions during sequential drug addition/removal. Table 4 ablates the contribution of this shaping by comparing the full GRPO model (with potential-based shaping) against a variant using only the base reward without shaping; all metrics are computed independently on held-out test data and are not derived from the training priors. To resolve the ambiguity, we will expand the description in §3.3 and revise the Table 4 caption to explicitly state that the ablation isolates the effect of the DDI prior on policy learning, separate from metric evaluation. This will better support the claim of fine-grained credit assignment. revision: yes

  2. Referee: [§4.3] §4.3, Table 2: superiority over baselines is reported, yet no error bars, multiple random seeds, or statistical significance tests are provided; this weakens the SOTA claim given the stochastic nature of LLM fine-tuning and GRPO.

    Authors: We agree that the stochasticity of LLM fine-tuning and GRPO makes error bars and statistical tests important for strengthening the SOTA claims. Our reported results used a single fixed random seed per configuration for reproducibility, as described in the experimental setup. In the revision, we will rerun the main experiments with multiple random seeds, report means and standard deviations in Table 2, add error bars, and include statistical significance tests (e.g., paired t-tests or Wilcoxon tests) with p-values against the strongest baselines in §4.3. These additions will be made to provide more rigorous evidence. revision: yes

Circularity Check

0 steps flagged

No significant circularity; derivation is self-contained

full rationale

The paper introduces FLAME as a sequential decision process for drug list generation using step-wise GRPO with potential-based reward shaping and enriched patient representations. No equations or derivations are presented that reduce a claimed prediction or result to a fitted input or self-citation by construction. The central performance claims rest on experimental evaluations across benchmark datasets using standard metrics, which constitute independent external validation rather than internal redefinition. No self-citation load-bearing steps, ansatz smuggling, or renaming of known results are identifiable from the provided manuscript content.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

Abstract-only review prevents identification of specific free parameters or axioms; no explicit invented entities mentioned.

pith-pipeline@v0.9.0 · 5723 in / 1016 out tokens · 41824 ms · 2026-05-22T02:31:34.744985+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. Medical Reasoning with Large Language Models: A Survey and MR-Bench

    cs.CL 2026-03 accept novelty 5.0

    LLMs show strong exam performance on medical tasks but exhibit a clear gap in accuracy on authentic clinical decision-making as measured by the new MR-Bench benchmark and unified evaluations.

Reference graph

Works this paper leans on

27 extracted references · 27 canonical work pages · cited by 1 Pith paper · 2 internal anchors

  1. [1]

    Deep learning for medication recommendation: a systematic survey,

    Z. Ali, Y . Huang, I. Ullah, J. Feng, C. Deng, N. Thierry, A. Khan, A. U. Jan, X. Shen, W. Rui, et al., “Deep learning for medication recommendation: a systematic survey,”Data Intelligence, vol. 5, no. 2, pp. 303–354, 2023

    work page 2023

  2. [2]

    Debiased, longitudinal and coordinated drug recommendation through multi-visit clinic records,

    H. Sun, S. Xie, S. Li, Y . Chen, J.-R. Wen, and R. Yan, “Debiased, longitudinal and coordinated drug recommendation through multi-visit clinic records,” Advances in Neural Information Processing Systems, vol. 35, pp. 27837–27849, 2022

    work page 2022

  3. [3]

    Safedrug: Dual molecular graph encoders for recommending effective and safe drug combinations,

    C. Yang, C. Xiao, F. Ma, L. Glass, and J. Sun, “Safedrug: Dual molecular graph encoders for recommending effective and safe drug combinations,” in30th International Joint Conference on Artificial Intelligence, IJCAI 2021, pp. 3735–3741, International Joint Conferences on Artificial Intelligence, 2021

    work page 2021

  4. [4]

    Conditional generation net for medication recom- mendation,

    R. Wu, Z. Qiu, J. Jiang, G. Qi, and X. Wu, “Conditional generation net for medication recom- mendation,” inProceedings of the ACM web conference 2022, pp. 935–945, 2022

    work page 2022

  5. [5]

    Leave no patient behind: Enhancing medication recommendation for rare disease patients,

    Z. Zhao, Y . Jing, F. Feng, J. Wu, C. Gao, and X. He, “Leave no patient behind: Enhancing medication recommendation for rare disease patients,” in Proceedings of the 47th International ACM SIGIR Conference on Research and Development in Information Retrieval, pp. 533–542, 2024

    work page 2024

  6. [6]

    Leap: learning to prescribe effective and safe treatment combinations for multimorbidity,

    Y . Zhang, R. Chen, J. Tang, W. F. Stewart, and J. Sun, “Leap: learning to prescribe effective and safe treatment combinations for multimorbidity,” inproceedings of the 23rd ACM SIGKDD international conference on knowledge Discovery and data Mining, pp. 1315–1324, 2017

    work page 2017

  7. [7]

    Gamenet: Graph augmented memory networks for recommending medication combination,

    J. Shang, C. Xiao, T. Ma, H. Li, and J. Sun, “Gamenet: Graph augmented memory networks for recommending medication combination,” inproceedings of the AAAI Conference on Artificial Intelligence, vol. 33, pp. 1126–1133, 2019

    work page 2019

  8. [8]

    Molerec: Combinatorial drug recommendation with substructure-aware molecular representation learning,

    N. Yang, K. Zeng, Q. Wu, and J. Yan, “Molerec: Combinatorial drug recommendation with substructure-aware molecular representation learning,” inProceedings of the ACM web confer- ence 2023, pp. 4075–4085, 2023

    work page 2023

  9. [9]

    Large language models encode clinical knowledge,

    K. Singhal, S. Azizi, T. Tu, S. S. Mahdavi, J. Wei, H. W. Chung, N. Scales, A. Tanwani, H. Cole-Lewis, S. Pfohl, et al., “Large language models encode clinical knowledge,”Nature, vol. 620, no. 7972, pp. 172–180, 2023

    work page 2023

  10. [10]

    Addressing overprescribing challenges: Fine-tuning large language models for medication recommendation tasks,

    Z. Zhao, C. Fan, C. Gao, F. Feng, and X. He, “Addressing overprescribing challenges: Fine-tuning large language models for medication recommendation tasks,” arXiv preprint arXiv:2503.03687, 2025

    work page arXiv 2025

  11. [11]

    Data-driven prediction of drug effects and interactions,

    N. P. Tatonetti, P. P. Ye, R. Daneshjou, and R. B. Altman, “Data-driven prediction of drug effects and interactions,”Science translational medicine, vol. 4, no. 125, pp. 125ra31–125ra31, 2012

    work page 2012

  12. [12]

    DeepSeekMath: Pushing the Limits of Mathematical Reasoning in Open Language Models

    Z. Shao, P. Wang, Q. Zhu, R. Xu, J. Song, X. Bi, H. Zhang, M. Zhang, Y . Li, Y . Wu,et al., “Deepseekmath: Pushing the limits of mathematical reasoning in open language models,” arXiv preprint arXiv:2402.03300, 2024

    work page internal anchor Pith review Pith/arXiv arXiv 2024

  13. [13]

    Aloe: A family of fine-tuned open healthcare llms,

    A. K. Gururajan, E. Lopez-Cuena, J. Bayarri-Planas, A. Tormos, D. Hinjos, P. Bernabeu-Perez, A. Arias-Duart, P. A. Martin-Torres, L. Urcelay-Ganzabal, M. Gonzalez-Mallo,et al., “Aloe: A family of fine-tuned open healthcare llms,”arXiv preprint arXiv:2405.01886, 2024

    work page arXiv 2024

  14. [14]

    Mimic-iii, a freely accessible critical care database,

    A. E. Johnson, T. J. Pollard, L. Shen, L.-w. H. Lehman, M. Feng, M. Ghassemi, B. Moody, P. Szolovits, L. Anthony Celi, and R. G. Mark, “Mimic-iii, a freely accessible critical care database,”Scientific data, vol. 3, no. 1, pp. 1–9, 2016

    work page 2016

  15. [15]

    Mimic-iv, a freely accessible electronic health record dataset,

    A. E. Johnson, L. Bulgarelli, L. Shen, A. Gayles, A. Shammout, S. Horng, T. J. Pollard, S. Hao, B. Moody, B. Gow, et al., “Mimic-iv, a freely accessible electronic health record dataset,” Scientific data, vol. 10, no. 1, p. 1, 2023. 10

    work page 2023

  16. [16]

    The eicu collaborative research database, a freely available multi-center database for critical care research,

    T. J. Pollard, A. E. Johnson, J. D. Raffa, L. A. Celi, R. G. Mark, and O. Badawi, “The eicu collaborative research database, a freely available multi-center database for critical care research,” Scientific data, vol. 5, no. 1, pp. 1–13, 2018

    work page 2018

  17. [17]

    Natural language-assisted multi-modal medication recommendation,

    J. Tan, Y . Rong, K. Zhao, T. Bian, T. Xu, J. Huang, H. Cheng, and H. Meng, “Natural language-assisted multi-modal medication recommendation,” inProceedings of the 33rd ACM International Conference on Information and Knowledge Management, pp. 2200–2209, 2024

    work page 2024

  18. [18]

    Proximal Policy Optimization Algorithms

    J. Schulman, F. Wolski, P. Dhariwal, A. Radford, and O. Klimov, “Proximal policy optimization algorithms,”arXiv preprint arXiv:1707.06347, 2017

    work page internal anchor Pith review Pith/arXiv arXiv 2017

  19. [19]

    Direct preference optimization: Your language model is secretly a reward model,

    R. Rafailov, A. Sharma, E. Mitchell, C. D. Manning, S. Ermon, and C. Finn, “Direct preference optimization: Your language model is secretly a reward model,”Advances in Neural Information Processing Systems, vol. 36, pp. 53728–53741, 2023

    work page 2023

  20. [20]

    Electronic health records to facilitate clinical research,

    M. R. Cowie, J. I. Blomster, L. H. Curtis, S. Duclaux, I. Ford, F. Fritz, S. Goldman, S. Janmo- hamed, J. Kreuzer, M. Leenay, et al., “Electronic health records to facilitate clinical research,” Clinical Research in Cardiology, vol. 106, pp. 1–9, 2017

    work page 2017

  21. [21]

    Process-supervised llm recommenders via flow-guided tuning,

    C. Gao, M. Gao, C. Fan, S. Yuan, W. Shi, and X. He, “Process-supervised llm recommenders via flow-guided tuning,”arXiv preprint arXiv:2503.07377, 2025

    work page arXiv 2025

  22. [22]

    Policy invariance under reward transformations: Theory and application to reward shaping,

    A. Y . Ng, D. Harada, and S. Russell, “Policy invariance under reward transformations: Theory and application to reward shaping,” inICML, pp. 278–287, Morgan Kaufmann, 1999

    work page 1999

  23. [23]

    David Rein, Betty Li Hou, Asa Cooper Stickland, Jackson Petty, Richard Yuanzhe Pang, Julien Dirani, Julian Michael, and Samuel R

    R. Rafailov, J. Hejna, R. Park, and C. Finn, “From r to q∗: Your language model is secretly a q-function,”arXiv preprint arXiv:2404.12358, 2024

    work page arXiv 2024

  24. [24]

    Collm: Integrating collaborative embeddings into large language models for recommendation,

    Y . Zhang, F. Feng, J. Zhang, K. Bao, Q. Wang, and X. He, “Collm: Integrating collaborative embeddings into large language models for recommendation,”IEEE Transactions on Knowledge and Data Engineering, 2025

    work page 2025

  25. [25]

    Llara: Large language- recommendation assistant,

    J. Liao, S. Li, Z. Yang, J. Wu, Y . Yuan, X. Wang, and X. He, “Llara: Large language- recommendation assistant,” inProceedings of the 47th International ACM SIGIR Conference on Research and Development in Information Retrieval, pp. 1785–1795, 2024

    work page 2024

  26. [26]

    Change matters: Medication change prediction with recurrent residual networks,

    C. Yang, C. Xiao, L. Glass, and J. Sun, “Change matters: Medication change prediction with recurrent residual networks,”arXiv preprint arXiv:2105.01876, 2021

    work page arXiv 2021

  27. [27]

    Mole-bert: Rethinking pre-training graph neural networks for molecules,

    J. Xia, C. Zhao, B. Hu, Z. Gao, C. Tan, Y . Liu, S. Li, and S. Z. Li, “Mole-bert: Rethinking pre-training graph neural networks for molecules,” 2023. 11 A Theoretical Analysis Proof. We prove the theorem using the reward shaping framework introduced by [22], which shows that augmenting a reward function with a potential-based shaping term does not alter t...

    work page 2023